🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

191 notícias encontradas para "drug"
Family of drugs used for treating muscular dystrophy could improve brain tumor treatment
Family of drugs used for treating muscular dystrophy could improve brain tumor treatment
A drug from the same family licensed for use in patients with Duchenne muscular dystrophy and blood cancer could transform the treatment of meningioma—the most common form of primary brain tumor in adults. Scientists at the Brain Tumor Research Center of Excellence at the Univers
Photoswitch drug shows early signs of restoring light sensitivity in severely damaged reti
Adelaide University researchers have carried out the first in-human trial of a new type of treatment for a leading cause of blindness in working age adults, with promising results.
Foto: Speak Media Uganda / Pexels
African genetic data could change how essential medicines are prescribed
The dosage information for drugs used in HIV treatment, malaria, cancer care, pain management and transplantation is largely based on data from European patients and fails to include vital information about how essential drugs work in diverse African populations. A Wits-led polic
Repurposed epilepsy drug could be used to boost vaccine protection among elderly
A drug commonly used to treat epilepsy could be repurposed to significantly boost the response to vaccines in humans, helping protect those for whom the vaccine is less effective, such as older adults or immunocompromised people. A Cambridge-led team showed that the drug more tha
Treating Duchenne muscular dystrophy before symptoms emerge may improve motor function, cl
At Binghamton University, researchers were among the first to find ways to help patients with Duchenne muscular dystrophy (DMD) through the development of an effective drug. Now, they are continuing that work, looking to reduce its effects even earlier.
Foto: Pixabay / Pexels
From caffeine to 'healthy' labeling, FDA sets year-end agenda for US food supply
The U.S. Food and Drug Administration (FDA) has announced the food supply issues it seeks to tackle by year's end. O recorte ajuda a contextualizar a pauta dentro de Fitness.
Australia relaxes psychedelic therapy oversight despite limited safety evidence
Australia relaxes psychedelic therapy oversight despite limited safety evidence
Psilocybin (the active ingredient of magic mushrooms) and MDMA (the active ingredient in ecstasy) are psychedelic or hallucinogenic drugs that can change how a person sees things and feels.
Foto: Anna Tarazevich / Pexels
Bacteria's 'mix-and-match' code could create new cancer-fighting drugs
A team of researchers at the University of Warwick and Monash University has solved a puzzle that has stumped drug developers for decades: how bacteria naturally create multiple versions of powerful cancer therapies. The breakthrough could accelerate the development of new treatm
GLP-1 drugs outperform SGLT-2 drugs for patients with Afib and type 2 diabetes
Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease and heart failure. These risks are significantly exacerbated if a type 2 diabetes diagnosis is added to the mix, says Md Mohaimenul Islam, Ph.D., resear
Discovery could help prevent cancer drug resistance before it starts
Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of California, Davis, shows how cancers adapt to evade a class of anti-tumor drugs called BET inhibitors and offers hope for more effective therapies.
Study identifies new brain targets for individualized epilepsy treatment
Study identifies new brain targets for individualized epilepsy treatment
Mayo Clinic researchers have created a detailed map of the pulvinar, a deep brain region that could help doctors more precisely target brain stimulation therapies for people with drug-resistant epilepsy.
FDA scientists warn against expanded peptide access as Kennedy reshapes advisory panel
FDA scientists warn against expanded peptide access as Kennedy reshapes advisory panel
Federal health scientists are urging caution about expanding access to controversial peptide drugs, even as the U.S. Food and Drug Administration (FDA) reshapes the advisory panel that will consider whether to loosen those restrictions.